Hepatic cirrhosis and decompensation: Key indicators for predicting mortality risk

Area of Science:

• Hepatology
• Internal Medicine
• Clinical Nutrition

Background:

• Liver cirrhosis is the advanced stage of chronic liver disease.
• Progression from compensated to decompensated cirrhosis significantly worsens patient prognosis.
• Accurate risk stratification is essential for managing cirrhotic patients.

Purpose of the Study:

• To highlight the limitations of current prognostic scores for liver cirrhosis.
• To emphasize the prognostic significance of body composition alterations, particularly sarcopenia.
• To advocate for the inclusion of body composition in comprehensive cirrhotic patient assessment.

Main Methods:

• Review of existing literature on liver cirrhosis prognosis.
• Analysis of validated scoring systems (MELD, Child-Pugh).
• Discussion of the impact of body composition and sarcopenia on outcomes.

Main Results:

• Current scores (MELD, Child-Pugh) do not fully capture prognostic factors.
• Sarcopenia and other body composition changes are linked to increased mortality risk.
• Body composition assessment offers complementary prognostic information.

Conclusions:

• Existing prognostic scores for liver cirrhosis are insufficient.
• Body composition, especially sarcopenia, is a critical, underutilized prognostic indicator.
• Integrating body composition analysis into patient assessment can enhance risk prediction and management strategies for liver cirrhosis.